Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: Short heparin-free hemodialysis helps to attenuate citrate load

Therapeutic Apheresis and Dialysis

Volumn 9, Issue 3, 2005, Pages 258-261

  Buturović Ponikvar, Jadranka ^a   Pernat, Andreja Marn ^a   Ponikvar, Rafael ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Citrate; Metabolic alkalosis; Plasma exchange; Regional citrate anticoagulation; Thrombotic thrombocytopenic purpura

Indexed keywords

ANTICOAGULANT AGENT; CITRATE TRISODIUM; PSEUDOMONIC ACID;

ADULT; ANTICOAGULATION; ARTIFICIAL KIDNEY; BLOOD GAS ANALYSIS; CASE REPORT; CATHETER INFECTION; CLINICAL ARTICLE; CONFERENCE PAPER; DIALYSIS; FEMALE; HEMODIALYSIS; HUMAN; INTENSIVE CARE UNIT; MEDICAL INSTRUMENTATION; METABOLIC ALKALOSIS; MONITOR; PLASMAPHERESIS; PRIORITY JOURNAL; REGIONAL CITRATE ANTICOAGULATION; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ALKALOSIS; ANTICOAGULANTS; BICARBONATES; CALCIUM; CALCIUM CHLORIDE; CITRIC ACID; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PLASMA; PLASMA EXCHANGE; POTASSIUM; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RENAL DIALYSIS;

EID: 23244465306     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1774-9987.2005.00267.x     Document Type: Conference Paper

References (13)

1. McCarthy LJ, Dlott JS, Orazi A, Waxman D, Miraglia CC, Danielson CFM. Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow. Ther Apher Dial 2004;8:80-6.
2. Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk of bleeding. N Engl J Med 1983;308:258-61.
3. Omokawa S, Malchesky PS, Yamashita M, Goldcamp JB, Nosé Y. Anticoagulant and membrane effects on humoral and cellular changer during plasmapheresis. Trans Am Soc Artif Intern Organs 1988;34:404-9.
4. Janssen MJFM, Huijgens PC, Bouman AA, Oe PL, Donker AJM, van der Meulen J. Citrate versus heparin anticoagulation in chronic hemodialysis patients. Nephrol Dial Transplant 1993;8:1228-33.
5. Ponikvar R, Buturović J, Čižman M et al. Hyperbaric oxygenation, plasma exchange and hemodialysis for treatment of acute renal failure in a 3-year-old child. Artif Organs 1998;22:952-7.
6. Ponikvar R, Buturoviæ J. Simultaneous protein A immunoadsorption and hemodialysis using citrate as the only anticoagulant in a patient with high risk of bleeding. Blood Purif 1997;15:A39.
7. Buturović J, Ponikvar R, Boh M, Kandus A, Klinkmann J, Ivanovich P. Filling of hemodialysis catheters in interdialytic period: heparin vs. citrate vs. polygeline. A prospective randomized study. Artif Organs 1998;22:945-7.
8. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976-81.
9. Janssen MJFM, Deegens JK, Kapinga TH et al. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients. Kidney Int 1996;49:806-13.
10. Ponikvar R, Buturović J, Benedik M, Urbančič A, Ličina A, Varl J. Hemodialysis in patients with high risk of hemorrhage: prostacyclin vs. citrate vs. heparin free HD. J Am Soc Nephrol 1995;6:A499.
11. Buturović J, Ponikvar R. Sequential citrate/heparin anticoagulation during hemodialysis with cuprophan membrane. Artif Organs 1997;21:A332.
12. Hofbauer RH, Moser D, Frass M et al. Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 1999;56:1578-83.
13. Kelleher SP, Schulman G. Severe metabolic alkalosis complication regional citrate hemodialysis. Am J Kidney Dis 1987;9:235-6.